Device Trial Radar · NCT03653858
Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression
Last checked: Nov 20, 2026Latest source record: Apr 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Sep 3, 2018
Primary completion
Jan 7, 2026
Study completion Jan 7, 2026
Sponsor
- Lead sponsor
- University Hospital FreiburgAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Boston Scientific Corporation
- First posted
- Aug 31, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 20 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this multicenter, randomized, sham-controlled, double blind (patient and observer blinded) clinical trial is to assess the antidepressant effect of Deep Brain Stimulation (DBS) in patients with treatment resistant major depression using the Boston Scientific implantable Vercise™ GEVIA™ DBS system compared to sham.
Conditions
- Treatment-resistant Depression
Interventions
Vercise GEVIA deep brain stimulation (DBS) systemDevice
DBS to the superolateral branch of the Medial Forebrain Bundle (slMFB)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery-Asberg Depression Rating Scale (MADRS) total scoreTime frame: 16 weeks after surgery
- Time to Montgomery-Asberg Depression Rating Scale (MADRS) augmentation of >5 points or clinical worsening in two consecutive visits after DBS terminationTime frame: Up to 3 months
- Assessment of (Serious) Adverse Events related to Investigational Medical Device and / or surgical proceduresTime frame: From IMD implantation until the end of study; assessed up to 77 weeks
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Université Grenoble Alpes
Grenoble, France
University Hospital Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.